Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04312997
Recruitment Status : Completed
First Posted : March 18, 2020
Last Update Posted : July 16, 2021
Sponsor:
Collaborator:
United States Department of Defense
Information provided by (Responsible Party):
Pulmotect, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2, 2021
Actual Study Completion Date : July 2, 2021